Former Conservative Party leader Erin O’Toole is criticizing the World Health Organization (WHO) for approving “less-effective” COVID-19 vaccines produced in communist China while rejecting a made-in-Canada version due to the Canadian company’s ties to a major tobacco company.
O’Toole was responding to news that the WHO has refused to accept Medicago Inc’s COVID-19 vaccine because U.S.-Swiss tobacco company Philip Morris International is a shareholder of the Quebec vaccine maker.
Medicago’s two-dose Covifenz vaccine was authorized by Health Canada in February for adults 18 to 64. In clinical trials, it was more than 70 percent effective at preventing COVID-19 infections and 100 percent effective against severe illness, prior to the Omicron wave.
WHO did not accept Medicago’s vaccine application because it has a strict policy not to engage with companies that promote tobacco, and Philip Morris owns about one-fifth of the company.
“Medicago was informed of this decision and has been apprised of WHO’s policies on tobacco,” the WHO said in a statement on March 25.
That policy could change, however, as the WHO begins a review of its policy options for health products linked to the tobacco industry.
“WHO is currently holding discussions on how to address a general trend of the tobacco industry investing in the health industry,” the organization said.
Experts have accused the Chinese Communist Party (CCP) of using locally produced vaccines to grow its international soft power, by giving vaccine doses to those that could not otherwise afford them.
Benjamin Gedan, deputy director of the Latin America program at the Wilson Center in Washington, called the practice “vaccine diplomacy”—a means to gain more political influence over those countries.
“It’s never encouraging to see the world’s largest dictatorships taking most advantage of this diplomatic opportunity,” said Gedan, referring to China and Russia, in an interview with The Canadian Press last April.
Gedan added at the time that China refused to give COVID-19 vaccines to Paraguay, which recognizes Taiwan diplomatically.
“There have been reports from the foreign minister of Paraguay that intermediaries of the Chinese government explicitly said that Paraguay will not access the Chinese vaccine unless it changes its position on Taiwan,” he said.
Another COVID-19 vaccine created by Tianjin-based biopharmaceutical company CanSino Biologics Inc., is pending final approval by the WHO before it rolls out to the international markets.